Japan Tobacco : Notice Concerning Amendments to Earnings Forecasts of a Subsidiary
January 20, 2020 at 01:24 am EST
Share
FOR IMMEDIATE RELEASE
Tokyo, January 20, 2020
Notice Concerning Amendments to Earnings Forecasts of a Subsidiary
Japan Tobacco Inc. (JT) (TSE: 2914) announces that Torii Pharmaceutical Co., Ltd. (Torii) (TSE:4551), our subsidiary company, amended its full-year earnings forecasts for the fiscal year ended December 31, 2019 (January 1, 2019 to December 31, 2019) as shown in the attached sheet.
The amendment will not have any material impact on the JT Group's consolidated performance.
(Attachment)
Torii Amends Full-Year Earnings Forecasts for Fiscal Year Ended December 31, 2019
###
Japan Tobacco Inc. is a leading international tobacco company with operations in more than 130 countries. With over 63,000 employees, it manufactures and sells some of the world's best-known brands including Winston, Camel, MEVIUS and LD. The JT Group is committed to investing in Reduced-Risk Products (RRP) and currently markets its tobacco vapor products under the Ploom brand and various e-cigarette products under the Logic brand. The Group is also present in the pharmaceutical and processed food businesses. For more information, visit https://www.jt.com/.
Contact:
Dinesh Babu Thotakura, General Manager
Media and Investor Relations Division
Japan Tobacco Inc.
Tokyo: +81-3-5572-4292
E-mail:jt.media.relations@jt.com
(Reference)
January 20, 2020
Torii Pharmaceutical Co., Ltd.
Torii Amends Full-Year Earnings Forecasts for Fiscal Year ended December 31, 2019
In consideration of the recent trend in earnings and other factors, Torii Pharmaceutical, Co., Ltd. ("Torii") has amended its full-year earnings forecasts for the fiscal year ended December 31, 2019, which were announced on October 31, 2019, as described below.
1. Amendments to Full-Year Earnings Forecasts for Fiscal Year Ended December 31, 2019 (January 1, 2019, to December 31, 2019)
Net sales
Operating
Ordinary
Net income
Net income
income
income
per share
(Millions of
(Millions of
(Millions of
(Millions of
(Yen)
yen)
yen)
yen)
yen)
Previous forecasts (A)
42,700
700
1,000
25,700
915.62
Amended forecasts (B)
42,990
1,430
1,690
27,360
974.71
Variance (B-A)
+290
+730
+690
+1,660
Variance rate (%)
+0.7
+104.3
+69.0
+6.5
(Reference)
Fiscal year ended
62,551
4,951
5,080
1,164
41.51
December 31, 2018
results
2. Amendments Details
Net Sales are expected to increase driven by the positive sales performance of allergen immunotherapy products, CEDARCURE® Japanese Cedar Pollen Sublingual Tablets.
Operating income and ordinary income are expected to exceed the previous forecasts, mainly driven by improved sales cost ratio and cost reduction initiatives which are expected to reduce selling, general and administrative expenses. Additionally, net income is also forecast to be higher as Torii recognized a deferred tax asset, which was not included in the previous forecast.
*The above-mentioned earnings forecasts are based on information available to Torii as of the date of this announcement. Actual business results may differ from the forecast figures herein.
Attachments
Original document
Permalink
Disclaimer
Japan Tobacco Inc. published this content on 20 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 January 2020 06:23:02 UTC
Japan Tobacco Inc. specializes in manufacturing and marketing of tobacco products. The group's products include primarily cigarettes, cigars, chewing and snuff tobaccos. Net sales break down by activity as follows:
- sale of tobacco products overseas (66%): 460 billion products sold in 2021, under the brands Winston, Camel, Silk Cut, Sobranie, Glamour, etc.;
- sale of tobacco products in Japan (24.1%): 67 billion products sold under the brands Cabin Prestige, Seven Stars, Pianissimo, Mild Seven, etc.;
- distribution of food products (6.3%);
- development of pharmaceutical products (3.5%): primarily for dyslipidemia, osteoporosis and Hepatitis C treatment;
- other (0.1%).
68.5% of net sales are abroad.